At Strongbridge Biopharma, our focus on rare diseases has resulted in a portfolio of innovative treatments for rare neuromuscular and endocrine conditions, including the commercialization of KEVEYIS in the U.S.
At Strongbridge Biopharma, we are committed to delivering better results for patients, healthcare providers, employees, and investors.
The Strongbridge team is passionate about making a positive difference in the lives of patients with rare diseases. It’s why we’re here.
For accessibility-related questions, comments, or concerns about this digital property, please email [email protected] and we will reply to your message.
© 2021 Strongbridge Biopharma plc
STRONGBRIDGE BIOPHARMA® is a registered trademark of the Strongbridge Biopharma plc. companies, which include Strongbridge Dublin Limited and Strongbridge U.S. Inc.
KEVEYIS® is a registered trademark licensed exclusively in the U.S. to Strongbridge Biopharma plc.
MLR-0010 V20 10/2020